Scarica l'app Stockscreener
28.76
0.93%
-0.27
Dopo l'orario di chiusura:
28.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RARE Giù?
Forum
Previsione
Frazionamento azionario
Ultragenyx Pharmaceutical Inc Borsa (RARE) Ultime notizie
Ultragenyx: The Setrusumab Reset Creates A Cleaner Rare Disease Opportunity - Seeking Alpha
RARE Stock Slumps On Multiple Wall Street Price Target Slashes, Clinical Pipeline Uncertainty - Stocktwits
Ultragenyx grants 44,409 restricted stock units to 15 new non-executive officers as an inducement. - Pluang
Ultragenyx awards 44,409 RSUs to 15 new hires - Stock Titan
RARE Stock Edges Up On Priority Review For Gene Therapy In Rare Metabolic Disorder - Stocktwits
Ultragenyx Pharmaceutical Inc (RARE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ultragenyx Pharmaceutical Inc - TradingKey
Ultragenyx Pharmaceutical Inc (RARE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ultragenyx Pharmaceutical Inc (RARE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ultragenyx Pharmaceutical Inc (RARE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Ultragenyx Pharmaceutical Inc (RARE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ultragenyx Pharmaceutical Inc (RARE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Ultragenyx Pharmaceutical Inc (RARE) Institutional Confidence - TradingKey
Why (RARE) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Ultragenyx (RARE) Is Up 17.6% After ESOP Share Shelf And Conference Spotlight On Gene Therapies – Has The Bull Case Changed? - simplywall.st
Ultragenyx Pharmaceutical Inc (RARE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Insider Sell Alert: Sanders Corazon (Corsee) D. Sells Shares of Ultragenyx Pharmaceutical Inc (RARE) - GuruFocus
Ultragenyx EVP sells $46,753 in common stock By Investing.com - Investing.com Australia
Ultragenyx director Corazon D. Sanders sells $50,100 in stock - Investing.com
Ultragenyx EVP sells $46,753 in common stock - Investing.com
Ultragenyx director Corazon D. Sanders sells $50,100 in stock By Investing.com - Investing.com Canada
Ultragenyx (RARE) director sells 2,000 shares at $25.05 - Stock Titan
Ultragenyx (RARE) legal chief sells 1,899 company shares in open market - Stock Titan
[144] Ultragenyx Pharmaceutical Inc. SEC Filing - Stock Titan
RARE (NASDAQ) proposed sale of 2,000 restricted shares by broker-dealer - Stock Titan
Ultragenyx Pharmaceutical (RARE) Gains 1.5% as Stock Tests Key Resistance Near $25.57Stop Hunt - newsline.com
Here is Why Ultragenyx Pharmaceutical (RARE) is One of the Best Buy-the-Dip Stocks - Insider Monkey
Ultragenyx Pharmaceutical Inc. $RARE Stock Holdings Lifted by GW&K Investment Management LLC - MarketBeat
Motley Fool Wealth Management LLC Lowers Position in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Los Angeles Capital Management LLC Sells 60,515 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
RARE: Transformative year ahead with pivotal data, gene therapy launches, and path to profitability - TradingView
RARE: Phase III Angelman data and gene therapy launches set the stage for profitability by 2027 - TradingView
How The Ultragenyx Pharmaceutical (RARE) Investment Story Is Shifting With New Data And Street Views - Yahoo Finance
Ultragenyx Pharmaceutical Inc. $RARE Shares Acquired by BNP Paribas Financial Markets - MarketBeat
Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Institutional Confidence in GTX-102 Fuels Optimism for Ultragenyx Pharmaceutical (RARE) - Insider Monkey
Ultragenyx EVP and chief medical officer Crombez sells $8,586 in shares - Investing.com Nigeria
Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm - Morningstar
Ultragenyx (RARE) Down 13.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference - The Manila Times
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year - AOL.com
Insider Sell: Howard Horn Sells Shares of Ultragenyx Pharmaceuti - GuruFocus
Ultragenyx CFO Horn sells $110,601 in company stock By Investing.com - Investing.com Australia
Insider Selling: Ultragenyx Pharmaceutical (NASDAQ:RARE) CFO Sells 4,653 Shares of Stock - MarketBeat
Ultragenyx CFO Horn sells $110,601 in company stock - Investing.com
Ultragenyx Pharmaceutical (RARE) CFO sells 4,653 common shares - Stock Titan
Ultragenyx (RARE) Pushes Higher on Positive Clinical Momentum – Key Levels to WatchNarrow Range Breakout - newsline.com
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):